Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy

• Michael J. Strong ,

  Contributed equally to this work with: Michael J. Strong, Guorong Xu

  Affiliations Department of Pathology, Tulane University, New Orleans, Louisiana, United States of America, Tulane Cancer Center, New Orleans, Louisiana, United States of America

  ⨯
• Guorong Xu ,

  Contributed equally to this work with: Michael J. Strong, Guorong Xu

  Affiliation Department of Computer Science, University of New Orleans, New Orleans, Louisiana, United States of America

  ⨯
• Joseph Coco,

  Affiliation Department of Computer Science, University of New Orleans, New Orleans, Louisiana, United States of America

  ⨯
• Carl Baribault,

  Affiliations Tulane Cancer Center, New Orleans, Louisiana, United States of America, Department of Mathematics, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Dass S. Vinay,

  Affiliation Department of Medicine, Section of Clinical Immunology, Allergy, and Rheumatology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Michelle R. Lacey,

  Affiliations Tulane Cancer Center, New Orleans, Louisiana, United States of America, Department of Mathematics, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Amy L. Strong,

  Affiliation Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, Louisiana, United States of America

  ⨯
• Teresa A. Lehman,

  Affiliation BioServe Biotechnologies, Ltd., Beltsville, Maryland, United States of America

  ⨯
• Michael B. Seddon,

  Affiliation BioServe Biotechnologies, Ltd., Beltsville, Maryland, United States of America

  ⨯
• Zhen Lin,

  Affiliations Department of Pathology, Tulane University, New Orleans, Louisiana, United States of America, Tulane Cancer Center, New Orleans, Louisiana, United States of America

  ⨯
• Monica Concha,

  Affiliations Department of Pathology, Tulane University, New Orleans, Louisiana, United States of America, Tulane Cancer Center, New Orleans, Louisiana, United States of America

  ⨯
• Melody Baddoo,

  Affiliations Department of Pathology, Tulane University, New Orleans, Louisiana, United States of America, Tulane Cancer Center, New Orleans, Louisiana, United States of America

  ⨯
• MaryBeth Ferris,

  Affiliation Department of Microbiology & Immunology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Kenneth F. Swan,

  Affiliation Department of Obstetrics and Gynecology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Deborah E. Sullivan,

  Affiliation Department of Microbiology & Immunology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Matthew E. Burow,

  Affiliations Tulane Cancer Center, New Orleans, Louisiana, United States of America, Department of Medicine, Section of Hematology and Medical Oncology, Tulane University, New Orleans, Louisiana, United States of America

  ⨯
• Christopher M. Taylor ,

  * E-mail: ctay15@lsuhsc.edu (CMT); eflemin@tulane.edu (EKF)

  Affiliations Department of Computer Science, University of New Orleans, New Orleans, Louisiana, United States of America, Department of Microbiology, Immunology & Parasitology, Louisiana State University School of Medicine, New Orleans, Louisiana, United States of America, Research Institute for Children, Children's Hospital, New Orleans, Louisiana, United States of America

  ⨯
•  [ ... ],
• Erik K. Flemington

  * E-mail: ctay15@lsuhsc.edu (CMT); eflemin@tulane.edu (EKF)

  Affiliations Department of Pathology, Tulane University, New Orleans, Louisiana, United States of America, Tulane Cancer Center, New Orleans, Louisiana, United States of America

  ⨯
• [ view all ]
• [ view less ]